195 related articles for article (PubMed ID: 35538890)
1. Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma.
Zhang T; Cui Y; Wu Y; Meng J; Han L; Zhang J; Zhang C; Yang C; Chen L; Bai X; Zhang K; Wu K; Sack MN; Wang L; Zhu L
Clin Transl Med; 2022 May; 12(5):e852. PubMed ID: 35538890
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial General Control of Amino Acid Synthesis 5 Like 1 Regulates Glutaminolysis, Mammalian Target of Rapamycin Complex 1 Activity, and Murine Liver Regeneration.
Wang L; Zhu L; Wu K; Chen Y; Lee DY; Gucek M; Sack MN
Hepatology; 2020 Feb; 71(2):643-657. PubMed ID: 31344750
[TBL] [Abstract][Full Text] [Related]
3. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.
Yu D; Shi X; Meng G; Chen J; Yan C; Jiang Y; Wei J; Ding Y
Oncotarget; 2015 Apr; 6(10):7619-31. PubMed ID: 25844758
[TBL] [Abstract][Full Text] [Related]
4. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
5. Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.
Liu J; Zhang C; Lin M; Zhu W; Liang Y; Hong X; Zhao Y; Young KH; Hu W; Feng Z
Oncotarget; 2014 May; 5(9):2635-47. PubMed ID: 24797434
[TBL] [Abstract][Full Text] [Related]
6. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway.
Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J
Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856
[TBL] [Abstract][Full Text] [Related]
7. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
[TBL] [Abstract][Full Text] [Related]
9. The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial β-oxidation enzyme HADHA.
Thapa D; Wu K; Stoner MW; Xie B; Zhang M; Manning JR; Lu Z; Li JH; Chen Y; Gucek M; Playford MP; Mehta NN; Harmon D; O'Doherty RM; Jurczak MJ; Sack MN; Scott I
J Biol Chem; 2018 Nov; 293(46):17676-17684. PubMed ID: 30323061
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells.
Kuo TC; Chen CK; Hua KT; Yu P; Lee WJ; Chen MW; Jeng YM; Chien MH; Kuo KT; Hsiao M; Kuo ML
Cancer Lett; 2016 Dec; 383(2):282-294. PubMed ID: 27725225
[TBL] [Abstract][Full Text] [Related]
11. Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1.
Han L; Zhang C; Wang D; Zhang J; Tang Q; Li MJ; Sack MN; Wang L; Zhu L
Oncogene; 2023 Mar; 42(13):1024-1037. PubMed ID: 36759571
[TBL] [Abstract][Full Text] [Related]
12. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension.
Dikalova A; Fehrenbach D; Mayorov V; Panov A; Ao M; Lantier L; Amarnath V; Lopez MG; Billings FT; Sack MN; Dikalov S
Circ Res; 2024 May; 134(11):1451-1464. PubMed ID: 38639088
[TBL] [Abstract][Full Text] [Related]
14. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
[TBL] [Abstract][Full Text] [Related]
15. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-specific deletion of GCN5L1 in mice restricts mitochondrial protein hyperacetylation in response to a high fat diet.
Thapa D; Manning JR; Stoner MW; Zhang M; Xie B; Scott I
Sci Rep; 2020 Jun; 10(1):10665. PubMed ID: 32606301
[TBL] [Abstract][Full Text] [Related]
17. Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.
Chen T; Yuan Z; Lei Z; Duan J; Xue J; Lu T; Yan G; Zhang L; Liu Y; Li Q; Zhang Y
Theranostics; 2022; 12(17):7450-7464. PubMed ID: 36438486
[No Abstract] [Full Text] [Related]
18. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
19. GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.
Suzuki S; Venkatesh D; Kanda H; Nakayama A; Hosokawa H; Lee E; Miki T; Stockwell BR; Yokote K; Tanaka T; Prives C
Cancer Res; 2022 Sep; 82(18):3209-3222. PubMed ID: 35895807
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart.
Thapa D; Zhang M; Manning JR; Guimarães DA; Stoner MW; O'Doherty RM; Shiva S; Scott I
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H265-H274. PubMed ID: 28526709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
